HIGHLIGHTS
- who: Vladimir Bezrookove from the The University of Iowa, United States have published the paper: BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target, in the Journal: (JOURNAL)
- what: The authors assess the biological role of BPTF in human breast cancer. The authors report substantial copy number gain of BPTF, assess the functional consequences of BPTF gene silencing in distinct subtypes of breast cancer, and explore the therapeutic consequences of bromodomain inhibition in_vivo. As a result of these observations, the authors focused the attention on the functional effects of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.